• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Argenx

Anonymous board for Argenx
Replies
1K
Views
279K
anonymous
Replies
1
Views
1K
anonymous
Replies
21
Views
6K
anonymous
Replies
9
Views
4K
anonymous
Replies
0
Views
947
anonymous
Replies
0
Views
1K
anonymous
NCM
Replies
8
Views
3K
anonymous
Replies
1
Views
2K
anonymous
Replies
0
Views
885
anonymous
Replies
1
Views
2K
anonymous
Replies
3
Views
4K
anonymous
Replies
1
Views
4K
anonymous